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ABSTRACT
Multidrug resistance (MDR), virulence and transferable elements potentiate Pseudomonas 
aeruginosa’s role as an opportunistic pathogen creating a high risk for public health. In this 
study, we evaluated the possible association of multidrug resistance, virulence factors and 
integrons with intrahospital P. aeruginosa strains isolated from patients at Cumana hospital, 
Venezuela. Relevant clinical-epidemiological data were collected to study 176 strains 
(2009-2016) isolated from different hospital units. Bacterial resistance was classified as 
susceptible, low-level resistant (LDR), multidrug resistant (MDR) and extensively drug-
resistant (XDR). Most strains produced pyoverdine, DNase, gelatinase and hemolysin. Around 
73% of the strains showed some type of movement. MDR and XDR strains increased from 
2009 (24.2% and 4.8%, respectively) to 2016 (53.1% and 18.8%); while LDR decreased 
from 64.5% to 6.3%. The exoU and exoS genes were found in a significant number of strains 
(38.1 and 7.4%, respectively). Class I integrons were detected in 35.8% of the strains and 
the frequency was associated with resistance (42.9, 22.4, 41.4 and 61.9%, for susceptible, 
LDR, MDR and XDR, respectively). The MDR/XDR strains were positively associated 
with hemolysins and exoU, but negatively associated with bacterial twitching. MDR/XDR 
phenotypes were also associated with the Intensive Care Unit (ICU), septicemia, bronchial 
infection and diabetic foot ulcers, as well as long hospital stay (≥10 days) and previous 
antimicrobial treatment. High frequency of MDR/XDR strains and their association with 
class I integrons and virulence factors can increase the infection potential, as well as morbidity 
and mortality of patients attending this hospital and could spread infection to the community, 
creating a health risk for the region.
KEYWORDS: Pseudomonas aeruginosa. Virulence factors. MDR. XDR. Integrons. Type 
III Secretion Systems.
INTRODUCTION
P. aeruginosa is a ubiquitous environmental bacterium that causes numerous 
opportunistic human infections, which are clinically and epidemiologically 
relevant due to the difficulty associated with the treatment of these infections and 
the transmission of resistance mechanisms. They can remain in the environment, 
producing repeated relapses in inpatients, increasing their morbidity and mortality, 
as well as health care costs1.
The pathogenicity of Pseudomonas is associated with numerous virulence 
factors, such as the presence of lipopolysaccharides, pili and flagella, which are all 
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part of the cell structure, as well as other factors synthesized 
by the cell and excreted into the surrounding tissue, where 
the infection develops, such as toxins, proteolytic enzymes, 
DNases and pigments2. Biofilm formation is another 
virulence factor due to the biofilm’s inherent resistance 
to antimicrobial agents and the selection of phenotypic 
variants. P. aeruginosa biofilm presents different resistance 
mechanisms that make it clinically responsible for many 
chronic infections, controlled by quorum sensor systems 
that regulate the transformation from planktonic cells into 
sessile ones3.
It has also been shown that, depending on the type of 
infection, P. aeruginosa can adapt by changing its iron uptake 
system using pyoverdine or pyochelin, characterized by their 
high and low affinity for iron, respectively, which in turn 
activate the production of acute virulence factors. The success 
of P. aeruginosa in causing infections is determined by a 
complex interaction between pathogenicity, antimicrobial 
resistance and regulation networks interconnecting resistance 
and virulence4 and these interactions are currently the subject 
of numerous studies. 
Multidrug resistant (MDR) P. aeruginosa strains are 
capable of colonizing environments and multiplying in 
conditions in which the rest of bacterial species are unable, 
granting them an evolutionary advantage and a better 
ability to cause epidemic outbreaks. In a hospital setting, 
a pathogen must be virulent and resistant to antimicrobials 
for an infection to persist, leading to increased patient 
morbidity5. In this sense, integrons, which are mobile 
genetic elements that can carry bacterial genes, have also 
been considered responsible for the spread of resistance to 
many antimicrobial agents; they are not essential to bacteria, 
but can provide additional genes that allow them to better 
adapt to their environment6.
In Venezuela, antimicrobial agents are frequently 
prescribed to the population, and currently, hospitals have a 
limited supply of drugs for their patients’ therapies, resulting 
in an increasing frequency of MDR P. aeruginosa due to 
the lack of timely and adequate treatments7. Since 1989, the 
presence of P. aeruginosa has been reported in intrahospital 
infections in Venezuela, with different resistances to beta-
lactam antibiotics, aminoglycosides and quinolones8-10. 
Reports of MDR P. aeruginosa strains began with metallo-
beta-lactamase positive strains reported in 200411 up to 
MDR strains found in several hospitals12. However, there 
are no studies evaluating the simultaneous presence of 
virulence factors, resistance genes and mobile genetic 
elements in this species, even though they are essential to 
understand the pathogen’s behavior and to design adequate 
therapeutic and control strategies to fight these organisms. 
Therefore, the objective of the present study was to evaluate 
how the virulence factors, resistance genes and integrons 
are affecting the epidemiological outcome of P. aeruginosa 
strains isolated from patients in the general hospital of 
Cumana, Venezuela.
MATERIALS AND METHODS
Study population and bioethical standards 
We evaluated 176 P. aeruginosa strains isolated from 
patients diagnosed with clinical infections and indications of 
culture and antibiogram performed in the Antonio Patricio 
de Alcala University Hospital (HUAPA) in Cumana, 
collected from June to December 2009 (62 strains), January 
to December 2010 (42 strains), February to December 
2012 (40 strains), and January to June 2016 (32 strains). 
Clinical and epidemiological relevant data were collected 
from patients, after the signature of an informed consent 
form. Each strain was isolated from a different individual, 
and they were independent of any epidemic outbreak. 
Biological samples and data collection were carried out 
following the guidelines established by the IIBCA-UDO 
biosecurity and bioethics committee (CoBioBios). The 
presence of infection was defined using criteria established 
by the Spanish Society of Infectious Diseases and Clinical 
Microbiology (SEIMC)13, which classifies an infection as a 
healthcare-associated infection (HAI) if the date on which 
the specific site of the infection is detected takes place at 
least 48 h after the patient’s admission14.
Toxin production
Hemolysins were produced in blood agar (8.0%) 
cultures. A transparent halo around the colonies indicated 
the presence of P. aeruginosa’s beta-hemolysin and the 
absence of a hemolysis halo was interpreted as a negative 
result15. Pigment production was evaluated in cetrimide agar 
cultures; targeted pigments were pyocyanin (blue-green), 
fluorescein (yellow), pyoverdine (green), pyorubin (red) 
and pyomelanin (brown)16.
Biofilm production 
Bacteria were cultured in LB media in 96-well plates 
to quantify the production of biofilm, using P. aeruginosa 
PA01 strain as a positive control17. A sterile broth was used 
as the negative control to ensure sterility and the absence of 
non- media-specific components. Strains were considered 
as non-biofilm producers when their optical densities were 
≤ 0.108 (≤ Average of Negative Control + 2σ) and biofilm 
producers when densities were > 0.108 (> ANC + 2σ).
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Motility tests 
Motility tests were carried out in sterile Petri dishes with 
Luria-Bertani agar (LB) using different concentrations of 
agar to evaluate swarming (0.5%), swimming (0.3%) and 
twitching (1.2%) as the different types of motility found 
in P. aeruginosa18 strains. Ten microliters of the media 
containing overnight cultured strains were inoculated 
on the agar surface for the swarming testing; while for 
swimming, 10 μL of the strains were inoculated into a thick 
agar by puncture; and for twitching, 10 μL of cultures were 
inoculated at the bottom of the agar. A well characterized 
Proteus mirabilis (LGM7881), swarming producer strain, and 
another well characterized immobile Klebsiella pneumoniae 
LGM1589 strain were used as positive and negative controls. 
All plates were incubated at 37 °C for 24 h. To assess the 
twitching motility, the agar was removed from the plate and 
25 mL of 1% crystal violet dye were added, incubated for 
30 min, then the stain was poured off the plate and air dried. 
Finally, the average diameters of the growing areas of the 
different types of motility were measured with a graduated 
ruler and expressed in millimeters (mm).
Enzymes production 
DNAse activity was studied using the DNAse test to rule 
out the presence of deoxyribonuclease19. A transparent halo 
around the colonies indicated nuclease activity, whereas 
the lack of a halo indicated a negative result. A Serratia 
marcescens strain (ATCC 1388) was used as the control. 
Pseudomonas’s capacity to produce proteolytic enzymes 
(gelatinases) was determined by using the puncture method 
in tubes containing 4% gelatin-agar. Total or partial medium 
hydrolysis attested the production of the enzyme (positive 
result), whereas a lack of hydrolysis was interpreted as a 
negative result20.
Resistance phenotypes 
The agar diffusion method was used to evaluate 
resistance to the following antimicrobials: piperacillin/
tazobactam (100/10 μg), aztreonam (30 μg), ceftazidime 
(30 μg), cefepime (30 μg), meropenem (10 μg), imipenem 
(10 μg), colistin (10 μg), polymyxin B (300 U), amikacin 
(30 μg), gentamicin (10 μg), tobramycin (10 μg), netilmicin 
(10 μg), levofloxacin (5 μg), norfloxacin (5 μg) and 
ciprofloxacin (5 μg). All essays were conducted using the 
criteria established by Clinical and Laboratory Standards 
Institute. Resistance phenotypes were defined using the 
guidelines established for P. aeruginosa21, and strains were 
characterized as low-level resistant (LDR, <3 antimicrobial 
categories), multidrug resistant (MDR, non-susceptible 
to ≥3 categories), extensively drug-resistant (XDR, non-
susceptible to all but ≤2 categories), and pandrug-resistant 
(PDR, non-susceptible to all antimicrobial categories) after 
testing all categories of microbial agents used in Venezuela, 
except for those for which this bacterium is intrinsically 
resistant. The quality of antimicrobial discs and biochemical 
tests was verified using Escherichia coli (ATTC 25922) and 
P. aeruginosa (ATTC 27853) as control strains.
Detection of genes 
DNA extraction was carried out using pure P. aeruginosa 
cultures. A Wizard Genomic DNA purification kit (Promega, 
Wisconsin, USA) was used for extraction according to the 
manufacturer’s specifications. The presence of the type 3 
secretion systems (SST3) exoS and exoU genes were detected 
by PCR using oligonucleotides ExoS-F/R (1587 pb) and 
ExoU-F/R (761 pb) according to Ajayi et al.22. Strains PA01 
and PA103 were assayed as positive controls for exoS and 
exoU, respectively. The detection of integrases int1-F/R 
(1202 pb), int2-F/R (973 pb) and int3-F/R (239 pb) genes was 
conducted based on the protocol described by Fonseca et al.23 
Amplified products were run in 2% agarose gels and stained 
with GelRed Nucleic Acid (Biotium, California, USA) using 
TBE 1X buffer for 30 min at 100 V cm. The size of the 
fragments was estimated using a molecular marker (100 pb 
from Promega, and Gene Ruler 1Kb plus from Thermo 
Fisher Scientific, Massachussets, USA). The resulting 
bands were visualized by transillumination with ultraviolet 
light, and all gels were photographically documented.
Analysis of data 
Results were presented in tables and figures. The 
relationships between MDR and the presence of virulence 
factors, clinical and epidemiological factors as well as 
integrons were evaluated by a binary logistic regression test, 
with a 95% confidence interval, using the SPSS statistical 
software, version 18. (IBM, New York, USA).
RESULTS
Identification of resistant phenotypes 
The present study demonstrated an increase in the 
frequency of resistant strains to beta-lactam antibiotics 
from 2009 to 2016, especially to carbapenems (Figure 1). 
Strains resistant to aminoglycosides have also increased, 
and even though the resistance to all fluoroquinolones 
remained ≥ 52.0% throughout the evaluated years and it has 
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slightly decreased in the strains isolated in 2012 and 2016. 
All strains were susceptible to polymyxin B and colistin. 
The frequency of Pseudomonas aeruginosa MDR and XDR 
phenotypes strains from HUAPA (Figure 2) increased from 
2009 to 2016, at the expense of the decrease of the LDR 
phenotype, showing a clear trend of resistance gain to more 
antibiotic categories. 
Virulence factors 
Pigment was the most common virulence factor produced 
by Pseudomonas aeruginosa strains (Figure 3A), followed 
by gelatinases, hemolysins and DNases (Figures 3B, 3C 
and 3D). About 40% of the strains showed biofilm and the 
different types of movement. The detection of exoS and exoU 
genes showed the latter to be more frequent (Figures 3A, 3E 
and 3F) and the simultaneous presence of exoS+exoU genes 
was found in only 1.7% of the strains.
The production of pyoverdine alone was the most 
frequently found bacterial phenotype (Figure 4A and 
4B1), followed by pyoverdine+fluorescein (Figure 4B6), 
no pigment (Figue 4B8) and pyoverdine+pyomelanin 
(Figure 4B7). Simultaneous pigment production was 
more evident when strains were subjected to antimicrobial 
susceptibility tests, which showed a halo of one of the 
pigments around the antimicrobial disc (Figure 4B1-7) and 
the other pigment spread across the plate. Additionally, the 
metallic sheen characteristic of P. aeruginosa (Figure 4B5) 
has also been observed in other three strains. 
Association of factors 
Production of DNases, gelatinase, biofilm and 
Figure 1 - Frequency of P. aeruginosa strains resistant to betalactamics (top) as well as aminoglycosides and quinolones (bottom). 
TZP: piperacillin/tazobactam, CAZ: ceftazidime, FEP: cefepime, ATM: aztreonam, IPM: imipenem, MEM: meropenem, GM: gentamicin, 
NN: tobramycin, NET: netilmicin, AK: amikacin, CIP: ciprofloxacin, LVX: levofloxacin; NOR: norfloxacin. 
Figure 2 - Distribution of P. aeruginosa strains resistant 
phenotypes throughout the years. Low-level resistant (LDR, 
<3 antimicrobial categories), Multidrug resistant (MDR, 
non-susceptible to ≥3), extensively drug-resistant strains (XDR, 
non-susceptible to all but ≤2 antimicrobial categories). 
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pigment was not statistically associated with the level of 
resistance shown by the strains (Table 1, Figure 5), whereas 
hemolysins production was directly related to resistance. In 
addition, the presence of the exoS gene was not statistically 
related to resistance, while exoU gene was significantly 
more frequent in MDR and XDR strains, compared to LDR 
and susceptible strains. 
When analyzing the types of movement shown by the 
strains, swarming but not swimming was directly correlated, 
while twitching was inversely correlated to the level of 
resistance (Table 1, Figure 5). When comparing the presence 
of any type of movement versus non-motile strains, we have 
also found an inverse correlation with the level of resistance.
An increase in the frequency of class I integrons has 
been observed for the years 2012 and 2016, compared to 
previous years (Figure 6). Additionally, a higher frequency 
of these sequences was found in XDR and MDR strains 
when compared to LDR ones, although sensitive strains 
have shown the same frequency as MDRs. 
The analysis of virulence factors as risk factors for MDR/
XDR resistance has shown that the presence of hemolysin, 
exoU gene and class I integrons has increased the risk of 
strains to present an MDR/XDR level of resistance 2.3, 
3.6 and 2.7 times higher, respectively (Table 1), while 
the presence of twitching reduced the risk of MDR/XDR 
resistance by 2.6 times.
Figure 3 - A) Frequency of the different virulence factors detected; example of the tests for the production of DNases (B), 
gelatinases (C), hemolysins (D), PCR amplification for P. aeruginosa exoS (E) and exoU (F) genes. bp: base pairs, M: molecular 
weight markers 100 bp ladder, C+: positive Control, C-: negative Control.
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Figure 4 - Relative frequency of types of pigments produced by P. aeruginosa strains: A) Examples of different pigments and 
pigment combinations produced in Mueller-Hinton agar with antibiotics; B) 1: pyoverdine, 2: fluorescein, 3: fluorescein + pyocyanin, 
4: pyomelanin, 5: pyoverdine + pyocyanin, 6: pyoverdine + fluorescein, 7: pyoverdine + pyomelanin, and 8: no pigment.
Epidemiological clinical factors 
When MDR was analyzed with respect to the presence 
of epidemiological clinical factors such as age, sex, 
hospital unit, type of sample, length of hospital stay and 
previous antimicrobial treatment, a statistically significant 
association (P <0.05) was found for some of these factors 
(Table 2). In this sense, patients treated at the Intensive 
Care Unit were 3.4 times more likely to become infected 
by an MDR/XDR P. aeruginosa strain than a LDR or a 
susceptible strain. In addition, patients with blood stream 
infection (septicemia), bronchial infection or diabetic foot 
ulcers were 7.9, 6.7 and 9.9 times more likely to be infected 
by an MDR/XDR P. aeruginosa strain, while patients with 
other types of infection (urine, sputum, ear swabs, eye and 
vagina) were 5 times less likely to be infected by an MDR/
XDR strain.
Furthermore, patients with longer hospital stay had a 2.3 
times higher risk to be infected by an MDR/XDR strain, 
while those with a previous antimicrobial treatment showed 
a 4.2 times higher risk of being infected by these strains.
DISCUSSION
The presence of MDR/XDR P. aeruginosa strains in 
the HUAPA hospital has increased over the past years. 
Teixeira et al.24 evaluated strains between 2010 and 2011 
and reported resistance to one or more antimicrobial agents 
in 65% of the analyzed strains. Data reported here on MDR 
and XDR strains have shown the severity of this medical 
issue for the patients attending this hospital due to the higher 
risk of morbidity and mortality and also the risk of spreading 
of resistant strains to the population living in this region. 
The increase of resistant strains of this species has a greater 
impact because of the natural resistance mechanisms that 
this bacterial species has.
Although most beta-lactam antibiotics are faced with 
lower resistance than carbapenems, this high resistance to 
carbapenems should be highlighted and it is probably due 
to the indiscriminate use of carbapenems in this particular 
hospital or to the lack of a controlled use of carbapenems in 
intrahospital infections, leading to the emergence of MDR 
strains. Other studies have shown that P. aeruginosa strains 
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Table 1 - Statistical correlation of different virulence factors with P. aeruginosa strains MDR/XDR phenotypes. 
Virulence Factor
MDR/XDR
Total P OR(95% CI)
- +
DNAase
- 24 25 49 0.343
+ 70 57 127
Gelatinase - 10 16 26 0.106
+ 84 66 150
Hemolysin - 22 13 35 0.044 2.3(1.0-5.3)
+ 72 69 141
Pyoverdine - 11 3 14 0.062
+ 83 79 162
Fluorescein
- 69 64 133 0.479
+ 25 18 43
Pyomelanin - 89 77 166 0.725
+ 5 5 10
Swarming - 50 44 94 0.996
+ 41 33 74
Twitching - 43 54 97 0.005 0.4(0.2-0.8)
+ 48 23 71
Swimming - 51 51 102 0.271
+ 40 26 66
Movement
- 17 31 48 0.004 0.4(0.2-0.7)
+ 77 51 128
Biofilm - 56 45 101 0.776
+ 38 37 75
exoS - 87 76 163 0.974
+ 7 6 13
exoU - 71 38 109 <0.001 3.6(1.9-6.8)
+ 23 44 67
Integrase I - 70 43 113 0.003 2.7(1.4-5.0)
+ 24 39 63
P: probability, OR: Odds Ratio, CI: confidence interval.
Figure 5 - Frequency of P. aeruginosa strains that produce virulence factors according to the resistance phenotype described in 
Figure 2. Factors associated to MDR/XDR are highlighted with three asterisks. 
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isolated from patients subjected to prolonged antimicrobial 
treatments are more prone to adapt to antimicrobial agents 
and to become MDR strains; this selection phenomenon is 
the reason behind the difficulty to control infections caused 
by MDR strains25,26.
The percentages of MDR and XDR strains in the 
present study were higher than those reported by Vega 
and Dowzicky27 who studied antimicrobial susceptibility 
among gram-positive and gram-negative bacteria from 
Latin American between 2004 and 2015; a percentage of 
26.7% of MDR P. aeruginosa was found and the countries 
presenting the highest percentages of MDR P. aeruginosa 
isolates were Guatemala, Venezuela, Honduras and Brazil 
(43.8, 32.6, 31.9 and 31.5%, respectively).
Pigment production was the most frequent virulence 
factor in HUAPA strains throughout the evaluated periods, 
both in susceptible and LDR strains. Even though pigment 
production was somewhat higher in MDR and XDR 
strains, the difference was not statistically significant. The 
simultaneous production of pigments by P. aeruginosa 
strains from HUAPA was more evident when MDR and XDR 
strains were subjected to antimicrobial susceptibility tests. 
The presence of pigments is the distinctive characteristic 
of the fluorescens group of Pseudomonas species, and it is 
also an evidence of the increased virulence of strains found 
at this hospital. Pigments are necessary for infection to 
occur in patients. Moreover, pyoverdine and pyomelanin 
Table 2 - Statistical correlations of different patients’ clinical and epidemiological factors, (from whom P. aeruginosa was isolated), 
with MDR/XDR phenotypes.
Factor
MDR/XDR
P OR(95% CI)
- + Total
Units
Medical 38 27 65 0.871
ICU 10 26 36 0.030 3.4(1.2-10.2)
Surgery 18 9 27 0.462
Outpatient 13 10 23 0.748
Pediatric/Neonatal 15 10 25 0.807
Sample
Blood 7 12 19 0.003 7.9(2.1-30.2)
Bronchial secretion 11 16 27 0.003 6.7(2.0-23.0)
Diabetic foot ulcer 13 28 41 <0.001 9.9(3.1-31.9)
Skin secretion 40 21 61 0.117
Other a 23 5 28 0.002 0.2(0.1-0.6)
Stay Short (<10 days) 70 43 113 0.019 2.3(1.1-4.)
Long (≥10 days) 21 29 50
Sex Male 53 55 108 0.355
Female 35 27 62
Age
<10 years 13 11 24 0.964
10-60 years 52 41 93 0.721
>60 years 16 18 34 0.573
Previous antimicrobial 
treatment
No 78 44 122
<0.001 4.2(2.1-8.4)
Yes 16 38 54
P: probability, OR: Odds Ratio, CI: confidence interval. a Other types of samples: urine, sputum, ear swabs, eye and vagina.
Figure 6 - Frequency of P. aeruginosa strains containing class 
I integrons according to the resistance phenotype shown (top) 
and throughout the years (bottom). Resistant phenotypes as 
described in Figure 2.
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facilitate virulence, biofilm development allowing species 
to establish chronic infections4,28. Pigment combinations 
have been associated with the status or severity of infections 
caused by P. aeruginosa26.
Another important aspect of pyoverdine synthesis 
in P. aeruginosa is its quorum sensor (QS) regulation 
mechanism, which modulates the existence of other 
virulence factors such as proteases, exotoxins and biofilm4. 
Among the other virulence factors identified in HUAPA 
strains, such as gelatinases, hemolysins and DNases, only 
hemolysins were associated with MDR, but production of 
these factors is variable in P. aeruginosa strains. Georgescu 
et al.18 reported that the most frequently expressed soluble 
virulence factors are beta-hemolysins (83.3%) and 
gelatinases (66.7%) and less frequently DNases (16.7%), 
whereas Holban et al.29 reported an increase in DNases 
and a decrease in gelatinases in wound secretion isolates. 
In HUAPA strains, beta-hemolysin production plays 
an important role in spreading the infection and extending 
wounds, since these enzymes (which form pores on cell 
membranes) facilitate the invasion of Pseudomonas into 
eukaryotic cells, protecting the bacterium from the host’s 
defense mechanisms and the antimicrobial treatment14.
For their part, DNases have important implications for 
virulence because they degrade extracellular DNA that will 
be used as a source of nitrogen, carbon and phosphate; they 
support P. aeruginosa’s biofilm matrix maintenance and 
their role in cell signaling to induce the expression of genes 
essential for resistance to antibiotics have been evidenced, 
leading to evasion of the host immune system30. 
Gelatinase production in HUAPA strains was also an 
important virulence factor, since proteases degrade a variety 
of proteins, including matrix components of different cells. 
Galdino et al.31, studying clinical strains of P. aeruginosa 
from Brazil, observed that gelatinase and elastase activities 
and the level of production varied depending on the 
bacteria’s site of isolation and antimicrobial susceptibility.
Another virulence factor evaluated in the present 
study was SST3 (Secretion System Type 3) because of the 
detection of the exoS and exoU genes in HUAPA strains. 
The exoU gene was associated with MDR, and its highest 
frequency was found in wound and bronchial secretions and 
blood samples from HUAPA patients, which has also been 
reported by Holban et al.32, who detected higher proportions 
of positive results for exoS than for the exoU enzyme. These 
genes are traits of clinical P. aeruginosa strains that have 
exoU secretion, higher impact on mortality, persistence 
of chronic diseases and dissemination of P. aeruginosa 
infections in comparison the exoS strain secretors, but it 
can vary depending on the site and the characteristics of 
the disease33,34.
According to Feltman et al.33, exoS and exoU distribution 
is not random and the authors found that most isolates 
carrying exoS sequences lack exoU, and vice versa, which 
was confirmed by the results of 115 P. aeruginosa clinical 
and environmental isolates among which 82 contained exoS 
and 31 contained exoU, and only one isolate contained 
both genes. 
Production of biofilms by P. aeruginosa has been 
associated with an increase on antimicrobial resistance35,36, 
by means of resistance genes accumulation and also to 
the fact that biofilms matrix penetration is difficult for 
antimicrobial agents.
Resistance to antipseudomonal beta-lactam antibiotics 
is apparently proportional to the increment of infection 
chronicity, which is in turn associated with biofilm 
formation and pyoverdine production26. More studies on 
antimicrobial resistance and simultaneous production of 
virulence factors are essential to understand the behavior of 
pathogenenic bacteria and to develop effective therapeutic 
strategies6. 
Results of the present study showed that susceptible 
strains with class I integrons began to appear during the 
2012 period, possibly acquired by horizontal transference 
of MDR or XDR P. aeruginosa intrahospital strains and 
increased in number as well as integron acquisition. 
Integrons have resistance cassettes that may favor the 
presence of MDR strains, which has been reported 
in P. aeruginosa strains with class I integrons37-40. 
Integrons were found to be associated with MDR strains 
of Pseudomonas, however, Fonseca et al.23 found no 
correlations between the presence of class I integron and 
MDR in clinical P. aeruginosa strains. Other studies have 
shown that P. aeruginosa isolates from patients with a 
history of long antimicrobial treatment developed MDR/
XDR; long hospital stay and readmission to the Intensive 
Care Unit were associated with MDR in patients with 
bacteremia caused by this species41,42.
Results of the present study demonstrated that 
HUAPA strains increased their MDR throughout the 
different sampling periods; these strains were also 
characterized by the presence of different virulence 
factors (pigments, biofilms, among others) favoring 
infections by P. aeruginosa. However, only hemolysins, 
exoU genes and class I integrons were associated with 
MDR/XDR. 
The present study demonstrated that P. aeruginosa 
employs various mechanisms to maintain infection in 
patients admitted to the studied hospital; in addition to 
risk factors identified by the study (attending the Intensive 
Care Unit , previous antimicrobial treatment, long hospital 
stay), these conditions predispose patients to P. aeruginosa 
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MDR strains infections, which require infection-specific 
therapeutic, isolation and control measures to decrease 
both, the infection rate and the dissemination of bacterial 
resistance mechanisms in hospitals. 
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